Invention Grant
US09447378B2 Method for differentiating human embryonic stem cells into β-cells for the treatment of type I diabetes
有权
将人胚胎干细胞分化为β细胞用于治疗I型糖尿病的方法
- Patent Title: Method for differentiating human embryonic stem cells into β-cells for the treatment of type I diabetes
- Patent Title (中): 将人胚胎干细胞分化为β细胞用于治疗I型糖尿病的方法
-
Application No.: US13873020Application Date: 2013-04-29
-
Publication No.: US09447378B2Publication Date: 2016-09-20
- Inventor: Clark K. Colton , Amanda Dilenno , Jeffrey R. Millman
- Applicant: Massachusetts Institute of Technology
- Applicant Address: US MA Cambridge
- Assignee: Massachusetts Institute of Technology
- Current Assignee: Massachusetts Institute of Technology
- Current Assignee Address: US MA Cambridge
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/02 ; C12N5/071 ; C12N5/0735
Abstract:
The invention provides inter alia methods for differentiating embryonic stem cells into insulin producing cells, as well as compositions comprising such cells, and therapeutic uses of such compositions.
Public/Granted literature
- US20130287743A1 METHOD FOR DIFFERENTIATING HUMAN EMBRYONIC STEM CELLS INTO ß-CELLS FOR THE TREATMENT OF TYPE I DIABETES Public/Granted day:2013-10-31
Information query
